New study aims to cut unnecessary pacemakers after heart valve procedure

NCT ID NCT04139616

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a pre-set treatment plan for managing heart rhythm issues that can occur after transcatheter aortic valve replacement (TAVR). The goal is to reduce the number of patients who receive a permanent pacemaker while ensuring no one is put at risk of sudden cardiac death. Researchers will follow 2,000 patients to see if the standardized approach works better than current varied practices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pre-specified treatment algorithm for managing conduction disturbances

What this could lead to

If successful, this could establish a standard care pathway that reduces the need for permanent pacemakers after TAVR without increasing the risk of dangerous heart rhythm events.

What could go wrong

This is an observational study testing a management strategy, not a new drug or device. Results depend on how well hospitals follow the algorithm, and individual patient factors may still require pacemakers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve disorder atrioventricular block cardiac conduction defect progressive familial heart block, type 1A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IUCPQ

    RECRUITING

    Québec, Quebec, G1V 4G5, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••